[{"id":"a6bfdaac-ee2d-45dc-b720-7c6d3dbb474e","acronym":"","url":"https://clinicaltrials.gov/study/NCT02530047","created_at":"2021-06-23T23:53:04.080Z","updated_at":"2024-07-02T16:36:57.965Z","phase":"Phase 1","brief_title":"Mesenchymal Stem Cells (MSC) for Ovarian Cancer","source_id_and_acronym":"NCT02530047","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" IFNB1","pipe":"","alterations":" ","tags":["IFNB1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e mesenchymal stem cell- INFβ therapy"],"overall_status":"Completed","enrollment":" Enrollment 5","initiation":"Initiation: 05/16/2016","start_date":" 05/16/2016","primary_txt":" Primary completion: 06/13/2019","primary_completion_date":" 06/13/2019","study_txt":" Completion: 06/13/2019","study_completion_date":" 06/13/2019","last_update_posted":"2019-07-18"}]